KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Staar Surgical (STAA) Operating Leases (2019 - 2026)

Staar Surgical's Operating Leases history spans 8 years, with the latest figure at $32.5 million for Q1 2026.

  • For Q1 2026, Operating Leases fell 6.68% year-over-year to $32.5 million; the TTM value through Jan 2026 reached $32.5 million, down 6.68%, while the annual FY2026 figure was $32.5 million, 6.68% down from the prior year.
  • Operating Leases reached $32.5 million in Q1 2026 per STAA's latest filing, down from $33.8 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $35.4 million in Q2 2025 to a low of $26.0 million in Q3 2022.
  • Average Operating Leases over 5 years is $30.9 million, with a median of $31.5 million recorded in 2023.
  • Peak YoY movement for Operating Leases: surged 339.55% in 2022, then dropped 6.68% in 2026.
  • A 5-year view of Operating Leases shows it stood at $27.1 million in 2022, then grew by 15.81% to $31.4 million in 2023, then rose by 10.76% to $34.8 million in 2024, then dropped by 2.88% to $33.8 million in 2025, then dropped by 3.91% to $32.5 million in 2026.
  • Per Business Quant, the three most recent readings for STAA's Operating Leases are $32.5 million (Q1 2026), $33.8 million (Q3 2025), and $35.4 million (Q2 2025).